higher FCF number but 3.5 million NPAT for 6 months down from 5.1 this time last year ? annualise that and its 7 million in profit for a company worth 220 million.. bit expensive
- Forums
- ASX - By Stock
- BBN
- Ann: FY24 Half Year Investor Presentation
Ann: FY24 Half Year Investor Presentation, page-2
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BBN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.79 |
Change
0.005(0.28%) |
Mkt cap ! $241.4M |
Open | High | Low | Value | Volume |
$1.78 | $1.80 | $1.75 | $115.9K | 65.19K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 70129 | $1.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.80 | 4376 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 70129 | 1.770 |
1 | 302 | 1.765 |
1 | 302 | 1.760 |
1 | 302 | 1.755 |
1 | 2438 | 1.740 |
Price($) | Vol. | No. |
---|---|---|
1.800 | 4376 | 6 |
1.805 | 11479 | 6 |
1.810 | 41780 | 4 |
1.815 | 9232 | 3 |
1.820 | 14765 | 4 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
BBN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online